发明名称 |
PYRROLIDIN-2-ONES AS HDM2 LIGANDS |
摘要 |
<p>Disclosed are substituted 2-pyrrolidone compounds of Formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of Formula (I) include: (cis)-4-[1-(4-Bromo-benzyl)-2-(6-chloro-1H-indol-3-yl)-5-oxo-3-p-tolylsulfanyl-pyrrolidine-3-carbonyl]-piperazine-1-carboxylic acid ethylamide, cis-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-[(4-ethylphenyl)sulfanyl]-N-[3-(morpholin-4-yl)propyl]-5-oxopyrrolidine-3-carboxamide, trans-1-[(4-chlorophenyl)methyl]-2-(6-fluoro-1H-indol-3-yl)-N-[3-(morpholin-4-yl)propyl]-5-oxo-3-(phenylsulfanyl)pyrrolidine-3-carboxamide, and cis-2-(6-chloro-1-methyl-1H-indol-3-yl)-1-[(4-chlorophenyl)methyl]-3-[(4-methylphenyl)sulfanyl]-5-oxo-N-(pyridin-2-ylmethyl)pyrrolidine-3-carboxamide. Compounds according to formula (I) are inhibitors of HDM2 and/or MDM2 and are useful for treating cancer and viral infections.</p> |
申请公布号 |
NZ591073(A) |
申请公布日期 |
2012.11.30 |
申请号 |
NZ20090591073 |
申请日期 |
2009.09.15 |
申请人 |
PRIAXON AG |
发明人 |
KALINSKI, CEDRIC;ROSS, GUENTHER;BURDACK, CHRISTOPH;WEBER, LUTZ;KHAZAK, VLADIMIR |
分类号 |
C07D403/04;A61K31/4015;A61P31/00;A61P35/00;C07D207/277;C07D401/06;C07D401/12;C07D401/14;C07D403/14;C07D409/12;C07D409/14 |
主分类号 |
C07D403/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|